A open-label, comparative, multicenter, randomised, phase IV study to assess the efficacy of Seroquel and Chlorpromazine for the treatment Schizophrenia in Chinese patients for 8 weeks, Seroquel PhaseIV
Study identifier:5077CN001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A open-label, comparative, multicenter, randomised, phase IV study to assess the efficacy of Seroquel and Chlorpromazine for the treatment Schizophrenia in Chinese patients for 8 weeks, Seroquel PhaseIV
Medical condition
schizophrenia
Phase
Phase 4
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Oct 2002
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
-
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
